Identifying microRNAs as potential biomarkers of drug resistance in multiple myeloma patients: proof-of-concept study

被引：0
|
作者：
Bergantim, Rui [1 ,2 ,3 ]
da Silva, Sara Peixoto [2 ,3 ]
Pereira, Joana [2 ,3 ]
Pinto, Vanessa [2 ,3 ]
Sousa, Diana [2 ,3 ]
Matthiesen, Rune [4 ]
Guimaraes, Jose Eduardo [1 ,2 ,3 ]
Helena Vasconcelos, M. [2 ,3 ,5 ]
机构：
[1] Hosp Ctr Sao Joao, Clin Hematol, Porto, Portugal
[2] Univ Porto, I3S Inst Invest & Inovacao Saude, Porto, Portugal
[3] Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, Canc Drug Resistance Grp, Porto, Portugal
[4] NOVA Med Sch, CEDOC, Computat & Expt Biol, Lisbon, Portugal
[5] Dept Biol Sci, Lisbon, Portugal
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-058
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [1] Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma
    Allegra, Alessandro
    Ettari, Roberta
    Innao, Vanessa
    Bitto, Alessandra
    CELLS, 2021, 10 (02) : 1 - 20
  • [2] MicroRNAs as potential biomarkers of response to modified Atkins diet in treatment of adults with drug-resistant epilepsy: A proof-of-concept study
    Samoes, Raquel
    Cavalheiro, Ana
    Santos, Cristina
    Lopes, Joana
    Teixeira, Catarina
    Tavares, Maria Manuel
    Carvalho, Claudia
    Lemos, Carolina
    Pinho e Costa, Paulo
    Cavaco, Sara
    Chaves, Joao
    Leal, Barbara
    EPILEPSY RESEARCH, 2024, 208
  • [3] Identifying Potential Adverse Effects by Patients' Ratings A Proof-of-Concept Study of a Novel Approach
    Mago, Rajnish
    Kloos, Angelica
    Daskalakis, Constantine
    Shwarz, Michelle
    Rovner, Barry W.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (06) : 828 - 831
  • [4] A proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myeloma
    Kwan Yeung Wong
    Gareth J. Morgan
    Eileen M. Boyle
    Alfred Sze Lok Cheng
    Kevin Yuk-Lap Yip
    Chor Sang Chim
    Scientific Reports, 11
  • [5] A proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myeloma
    Wong, Kwan Yeung
    Morgan, Gareth J.
    Boyle, Eileen M.
    Cheng, Alfred Sze Lok
    Yip, Kevin Yuk-Lap
    Chim, Chor Sang
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] Circulating serum microRNAs as biomarkers of drug resistance in multiple myeloma patients treated with bortezomib-based regimens - pilot study
    Pula, Anna
    Robak, Tadeusz
    Drozdz, Izabela
    Stawiski, Konrad
    Rycerz, Aleksander
    Misiewicz, Malgorzata
    Robak, Pawel
    LEUKEMIA & LYMPHOMA, 2024, 65 (02) : 257 - 264
  • [7] Biomarkers of "Linguistic Anxiety'' in aphasia: A proof-of-concept case study
    Cahana-Amitay, Dalia
    Oveis, Abigail C.
    Sayers, Jesse T.
    Pineles, Suzanne L.
    Spiro, Avron, III
    Albert, Martin L.
    CLINICAL LINGUISTICS & PHONETICS, 2015, 29 (05) : 401 - 413
  • [8] Dynamic frailty-tailored therapy (DynaFiT): A proof-of-concept study in elderly patients with newly diagnosed multiple myeloma
    Dai, Yun
    Jin, Fengyan
    BLOOD SCIENCE, 2024, 6 (04):
  • [9] BIOMARKERS TO MONITOR RIGHT HEART PRESSURES IN HEART TRANSPLANTED PATIENTS - A PROOF-OF-CONCEPT STUDY
    Huang, Qi-Fang
    Trenson, Sander
    Zhang, Zhen-Yu
    Van Keer, Jan
    Van Aelst, Lucas
    Yang, Wen-Yi
    Nkuipou-Kenfack, Esther
    Thijs, Lutgarde
    Wei, Fang-Fei
    Ciarka, Agnieszka
    Droogne, Walter
    Vanhaecke, Johan
    Janssens, Stefan
    Van Cleemput, Johan
    Mischak, Harald
    Staessen, Jan
    JOURNAL OF HYPERTENSION, 2018, 36 : E96 - E97
  • [10] A Wireless Neuroprosthesis for Patients with Drug-refractory Epilepsy: A Proof-of-Concept Study
    Romanelli, Pantaleo
    Valiante, Taufik A.
    Seri, Stefano
    Puttilli, Cosimo
    Picciafuoco, Mauro
    Jakobs, Martin
    Lozano, Andres
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (10)
12345